EUVIMEDEUVIMED entdecken
Crossref

Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression

Shuhei Suzuki, Chifumi Kitanaka, Masashi Okada

Anticancer Research · 2024

DOI: 10.21873/anticanres.17214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Shuhei Suzuki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan; s-suzuki@med.id.yamagata-u.ac.jp. Hauptthemen laut MEDLINE: Glioblastoma, Survivin, alpha-MSH. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaSurvivinalpha-MSHHumansCell Line, TumorBrain NeoplasmsCell ProliferationReceptors, MelanocortinCell SurvivalInhibitor of Apoptosis ProteinsCell DeathGene Expression Regulation, NeoplasticApoptosisTemozolomideAntineoplastic Agents

Stichwörter der Autor:innen

Drug repositioningbremelanotidemelanocortin receptorsurvivin

Substanzen

Survivinalpha-MSHBIRC5 protein, humanReceptors, MelanocortinInhibitor of Apoptosis ProteinsMSH, 4-Nle-7-Phe-alpha-TemozolomideAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan; s-suzuki@med.id.yamagata-u.ac.jp.
  • Department of Clinical Oncology, Yamagata Prefectural Shinjo Hospital, Yamagata, Japan.
  • Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Research Institute for Promotion of Medical Sciences, Yamagata University Faculty of Medicine, Yamagata, Japan.

Zitieren

APA

Suzuki, S., Kitanaka, C., & Okada, M. (2024). Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression. Anticancer Research. https://doi.org/10.21873/anticanres.17214

Vancouver

Suzuki S, Kitanaka C, Okada M. Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression. Anticancer Research. 2024. doi:10.21873/anticanres.17214

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Shuhei and Kitanaka, Chifumi and Okada, Masashi},
  title = {Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17214}
}
Kostenlos starten →